Literature DB >> 18492516

Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia?

Arieh Riskin1, Ada Tamir, Amir Kugelman, Miri Hemo, David Bader.   

Abstract

OBJECTIVE: To assess the reliability of visual assessment of bilirubin levels (BiliEye) in newborns as a screening tool to detect significant neonatal hyperbilirubinemia. STUDY
DESIGN: 5 neonatologists and 17 nurses estimated 3,532 BiliEye in 1,129 term and late preterm (> or = 35 weeks) infants before discharge from the nursery, at 62 +/- 24 hours. Total serum bilirubin (TSB) levels were measured concomitantly.
RESULTS: Mean TSB and BiliEye were 6.7 +/- 2.9 mg/dL (range, 0.4-18.2 mg/dL) and 6.6 +/- 3.2 mg/dL (range, 0.0-17.2 mg/dL), respectively, with good correlation (Pearson's r = 0.752, P < .0001), but other measures of agreement were poor. 61.5% of the 109 babies with TSB levels in high-risk zones were clinically misclassified. The area under curve (AUC) of the receiver-operating characteristics plotted for these high-risk zones was 0.825, but became low for early discharge (< or = 36 hours; AUC = 0.638) and late preterm (35-37 weeks; AUC = 0.613). There was significant interobserver variation (low weighted kappa, 0.363).
CONCLUSIONS: Although there was good correlation between BiliEye and actual TSB level, visual assessment was unreliable as a screening tool to detect significant neonatal hyperbilirubinemia before discharge. Babies with TSB levels within high-risk zones may be clinically misdiagnosed as low-risk, resulting in inadequate follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492516     DOI: 10.1016/j.jpeds.2007.11.003

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Use of a Smartphone App to Assess Neonatal Jaundice.

Authors:  James A Taylor; James W Stout; Lilian de Greef; Mayank Goel; Shwetak Patel; Esther K Chung; Aruna Koduri; Shawn McMahon; Jane Dickerson; Elizabeth A Simpson; Eric C Larson
Journal:  Pediatrics       Date:  2017-09       Impact factor: 7.124

2.  Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.

Authors:  R Bromiker; A Goldberg; M Kaplan
Journal:  J Perinatol       Date:  2017-08-31       Impact factor: 2.521

3.  Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in bangladesh.

Authors:  Choudhury Habibur Rasul; Md Abul Hasan; Farhana Yasmin
Journal:  Malays J Med Sci       Date:  2010-04

4.  Data suggest visual assessment of jaundice in newborns is helpful.

Authors:  Thomas B Newman
Journal:  J Pediatr       Date:  2009-03       Impact factor: 4.406

Review 5.  Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Authors:  Christian V Hulzebos; Libor Vitek; Carlos D Coda Zabetta; Aleš Dvořák; Paul Schenk; Eline A E van der Hagen; Christa Cobbaert; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2021-05-03       Impact factor: 3.756

6.  Medical education content required for kernicterus risk recognition.

Authors:  Gláucia Macedo de Lima; Maria Amélia Sayeg Campos Porto; Antônio Ledo Alves da Cunha
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

7.  Development and validation of serum bilirubin nomogram to predict the absence of risk for severe hyperbilirubinaemia before discharge: a prospective, multicenter study.

Authors:  Costantino Romagnoli; Eloisa Tiberi; Giovanni Barone; Mario De Curtis; Daniela Regoli; Piermichele Paolillo; Simonetta Picone; Stefano Anania; Maurizio Finocchi; Valentina Cardiello; Lucia Giordano; Valentina Paolucci; Enrico Zecca
Journal:  Ital J Pediatr       Date:  2012-02-01       Impact factor: 2.638

8.  BiliCheck vs JM-103 in identifying neonates not at risk of hyperbilirubinaemia.

Authors:  Costantino Romagnoli; Piero Catenazzi; Giovanni Barone; Lucia Giordano; Riccardo Riccardi; Antonio Alberto Zuppa; Enrico Zecca
Journal:  Ital J Pediatr       Date:  2013-07-23       Impact factor: 2.638

9.  Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks' gestational age.

Authors:  Costantino Romagnoli; Giovanni Barone; Simone Pratesi; Francesco Raimondi; Letizia Capasso; Enrico Zecca; Carlo Dani
Journal:  Ital J Pediatr       Date:  2014-01-31       Impact factor: 2.638

10.  Maternal Blood Group and Routine Direct Antiglobulin Testing in Neonates: Is There a Role for Selective Neonatal Testing?

Authors:  Hwazen A Shash; Suzan A Alkhater
Journal:  Children (Basel)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.